Find the right Medicare plan for 2026 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy

Lakshmi Halasyamani, chief clinical officer at Endeavor Health, thinks value-based care isn’t really about payment models. To her, this work centers on understanding patients’ clinical, social and financial circumstances well enough to make care plans that actually work for their lives. The post Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders

Argenx’s first acquisition is the buyout of Forte Biosciences, a company with a lead drug that has early clinical validation in celiac disease and vitiligo. Argenx executives say this antibody complements its blockbuster product Vyvgart, offering a different mechanism of action but similar pipeline-in-a-product potential. The post Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders appeared first on MedCity News .

Read full article →
Senior Health MedPageToday.com - medical news for physicians

FDA Scientists Raise Questions About Duchenne Drug

(MedPage Today) -- FDA scientists said that investigational deramiocel, a stem cell treatment for Duchenne muscular dystrophy, did not meet its primary endpoint in a phase III trial, despite data presented at the American Academy of Neurology ...

Read full article →